from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3407/vapB47

LFCtreatmentdescriptionclass of inhibitor

-0.571

Amikacinug/mL Amikacintranslation

-0.651

Cap5-10ug/mL Capreomycintranslation

-1.089

Rox10-50 ug/mL Roxithromycintranslation

0.461

SM2-5 ug/mL Streptomycintranslation

-1.042

Tet5-10 ug/mL Tetracyclinetranslation

-2.668

Rif0.2-5ug/mL Rifampicintranscription

-2.785

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.160

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.308

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.376

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.223

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.232

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.062

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.311

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.129

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.066

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.375

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.302

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.205

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.663

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.213

KCN5-20 ug/mL Potassium cyaniderespiration

0.687

NaN30.2-2 mM Sodium aziderespiration

-0.433

Nigericin50 uM Nigericinrespiration

0.085

TRC10-150 ug/mL Triclosanrespiration

0.034

TRZ10-25 ug/mL Thioridazinerespiration

-1.326

Valinomycin0.5-10 uM Valinomycinrespiration

-0.342

ZnSO42 mM ZnSO4respiration

0.498

menadione6-10 ug/mL Menadionerespiration

0.452

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.425

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.225

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.295

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.174

NRP_1Non-replicating persistence stage 1dosRassociated

0.653

Amp0.2mg/mL AmpicillincellWall

0.266

Cephalexin20-100 ug/mL CephalexincellWall

0.447

Cerulenin0.32-5 ug/mL CerulenincellWall

0.011

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.216

EMB10-20 ug/mL EthambutolcellWall

0.774

Eta12-40 ug/mL EthionamidecellWall

0.952

INH0.2-0.4 ug/mL IsoniazidcellWall

0.087

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.070

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.180

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.288

BZA0.12 mg/mL BenzamidearomaticAmides

0.972

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.140

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.713

H2O24 mM hydrogen peroxideDNAdamaging

-0.229

Levo10 ug/mL LevofloxacinDNAdamaging

-0.384

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.205

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.096

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.087

UVUV-irradiationDNAdamaging

-0.764

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.114

Antimycin12.5-50 ug/mL Antimycin A?

0.007

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.761

PA_110-50 ug/mL Antitubercular compound PA-1?

0.458

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.200

PA8240.2-2 ug/mL PA-824?

0.748

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.218

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.225

Verapamil50 uM Verapamil?

0.012

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.249

methoxatin10-20 ug/mL Methoxatin?